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Abstract
Background: Cardiac morphologic and functional changes consistent with cardiomyopathy have been reported in
field cases of calves with accidental doxycycline overdosing. The purpose of this study was to evaluate clinically
the cardiac effects of an experimentally-induced doxycycline overdosing in healthy calves.
Twelve 2 months-old healthy Belgian Blue calves were studied. Six of them (group 1) received the normal dose (5
mg/kg, BID) and the six others (group 2) received five times the normal dose (25 mg/kg, BID) of oral doxycycline
for five consecutive days (D1 to D5). Each calf was clinically examined daily. Measurement of serum AST, CK, Iso-
CKs and LDH activities and an echocardiographic examination were performed before (D0) and one day after (D6)
the last doxycycline administration. An ECG tracing was recorded at D0, D4, and D6.
Results: In both groups, no clinical, blood, echocardiographic or electrocardiographic changes suggestive of a
cardiomyopathy were observed. Only a decreased appetite was observed in the calves of the group 2 between D3
and D6.
Conclusions: This trial failed to reproduce cardiac changes reported in accidental doxycycline-poisoning in calves,
suggesting that high doses of doxycycline may not be the only etiologic factor of the cardiomyopathy reported in
the field cases.
Background
Doxycycline is an excellent broad-spectrum antibiotic
for the treatment of respiratory diseases in calves [1]. It
is obtained semi-synthetically from oxytetracycline or
methacycline [2] and exerts a bacteriostatic effect by
inhibiting protein synthesis [3]. This molecule presents
better pharmacological properties than other tetracy-
clines [4], with an excellent penetration into tissues [3]
and a prolonged biological half-life [5]. Moreover, the
possibility of administering doxycycline to calves in milk
or milk replacer makes the treatment practically easy in
the field [1].
Several cases of severe, sometimes lethal, troubles
were reported in 2 to 16-weeks old calves after oral
intake of high doses of doxycycline [6-12]. In these
calves, clinical examination revealed mainly depression,
dyspnoea, cough, tongue paresia or paralysis associated
to dysphagia and sialorrhea, tachycardia, arrhythmias,
tachypnea and signs of myopathy [11,12]. Blood analysis
revealed an increase in creatine kinase (CK), lactate
dehydrogenase (LDH), aspartate aminotransferase (AST)
and sorbitol dehydrogenase (SDH) activities and in crea-
tinine and urea levels. Electrocardiographic (ECG)
records and Doppler echocardiography examination
revealed ventricular premature beats and a decrease in
left ventricular global and systolic function, respectively.
Necropsy and histopathology revealed evidence of
necrosis of the myocardium, of the tongue, of the skele-
tal and the respiratory muscles, and acute tubular necro-
sis in the kidneys and fatty degeneration or congestion
of the liver [6-12].
Cardiac dysfunction and necrotic cardiomyopathy
lesions after treatment with doxycycline have never been
described in other species including human beings,
either at normal doses or at overdosing. This could
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cific to the bovine species, and/or that predisposing fac-
tors could play a role in the doxycycline-induced
myocardial necrosis observed in calves in the field.
The purpose of this study was to evaluate clinically
the cardiac effects of a normal and a high dose of doxy-
cycline in healthy 2 months-old Belgian Blue (BB)
calves.
Methods
This study was performed according to the rules of
Good Laboratory Practice and Good Clinical Practice
(99/12/EEC and CPMP/ICH/135/95). The experimental
protocol used in this study followed the guidelines and
has been approved by the animal ethical committee of
the University of Liege (Ref. 966). Only calves consid-
ered healthy on the basis of clinical history and exami-
nation were included in the trial. It was decided that
calves that may show a dramatic decrease in their gen-
eral status during the experimentation will be immedi-
ately euthanized. The study was conducted as blind-trial.
Animals
Twelve BB healthy calves were studied and randomly
assigned to two groups. The day before starting the
experimental protocol (D0), the groups consisted of
Group 1: 6 calves (3 males and 3 females) that were
60 ± 0 days old and weighing 77 ± 5 kg.
Group 2: 6 calves (3 males and 3 females) that were
59 ± 1 days old and weighing 73 ± 7 kg.
Housing and feeding
During the experimentation, all calves were housed in
2.2 m
2 rubber mats floored individual boxes. Ambient
temperature and relative humidity were maintained
between 10 and 15°C, and between 70 and 80%, respec-
tively. From birth to the end of experimentation, the
calves of the two groups were fed with a commercial
milk replacer (Navobi
®,N e t h e r l a n d s ) .A tD 0 ,a l lt h e
calves received 640 g of this conventional milk replacer
dissolved in 5 litres twice daily. During the experimenta-
tion, the amount of milk powder was increased daily of
10 g/meal. At D5, the milk powder was dissolved in 5.5
litres/meal. All calves were kept on milk only and were
fed according to the same feeding schedule.
Doxycycline administration
Calves of group 1 received a standard dosage (5 mg/kg
BW) of oral doxycycline (DOXYVETO 50% PULVIS
®;
VMD) for five consecutive days (D1 to D5) BID, whilst
calves of group 2 received 5-fold the standard dosage
(25 mg/kg BW) of the same oral doxycycline for five
consecutive days (D1 to D5) BID. Doxycycline was
mixed to milk replacer and administrated to calves
during feeding time. Calves were nourished individually
in order to ensure that they all received the planned
doxycycline dose.
Clinical examination
All calves underwent a daily clinical examination from
D0 to one day after the last doxycycline administration
(D6) of the experimentation. Animals were examined 2
hours following their morning meal and before other
investigations (ECG, blood samples or echocardiogra-
phy) in order to avoid an effect of handling stress on
their physiological parameters. The daily clinical exami-
nation of the calves was performed by an experienced
veterinarian. The same operator examined all the calves
during all the study and was blind to the treatment of
the calves.
Blood analysis
Blood was sampled in all calves at D0 and D6 using a
venous jugular catheter. Blood was sampled in order to
measure serum CK, CK isoenzymes (Iso-CKs) including
muscle (Iso-CK MM), heart (Iso-CK MB), brain (Iso-CK
BB) and mitochondrial (Iso-CK MT) Iso-CKs, LDH and
AST activities. Measurements were performed using
commercial kits (Ecoline25
®, Ecoline15
®,a n dG r a n u t -
est25
® for AST, LDH, and CK, respectively; Diagnostica
Merk). Iso-CKs were evaluated by electrophoresis.
Electrocardiography
ECG tracings were recorded in all calves at D0, D4, and
D6 from a bipolar base-apex lead (Cardiofax V, Model
ECG-8240; Nihon Kohden) [13]. The electrocardiogram
was only recorded when the calves were resting. The
ECG tracings were analyzed manually for detection of
rhythm abnormalities.
Echocardiographic examination and measurements
An echocardiography was carried out on all calves at D0
and at D6 with a 2.5 MHz phased-array sector scanner
(RT6800; GE Medical Systems) and recorded on VHS
tapes for subsequent analysis. The operator performing
the echocardiography was blind to the treatment of the
calves. Terminology and image orientation were those
recommended by the Echocardiography Committee of the
Specialty of Cardiology, American College of Veterinary
Internal Medicine [14] and adapted for large animals [15].
Calves were examined standing. An ECG was recorded
simultaneously with the echocardiographic images.
Diastolic measurements were made at the onset of the
QRS complex or at largest left ventricular dimension.
Systolic measurements were made at smallest left ventri-
cular dimension (two-dimensional [2D-] mode) or peak
downward point of septal motion (time-motion [M-]
mode).
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Page 2 of 6The interventricular septal thicknesses (IVS) and the
left ventricular internal diameter (LVID) were measured
at end-diastole (d) and at end-systole (s) in an M-mode
right parasternal short-axis view of the left ventricle at
the level of the papillary muscles and the chordae tendi-
nae. From these measurements, the fractional shortening
(FS) of the left ventricle was calculated using the classi-
cal formula [15]. From LVID, end-diastolic (EDV) and
end-systolic (ESV) volumes were calculated using the
Teicholz method [16] as follows:
EDV = 7 × LVIDd
3/(2 . 4+L V I D d )
ESV = 7 × LVIDs3/(2 . 4+L V I D s )
The ejection fraction (EF) was calculated using the
classic formula [15]. The stroke index (SI) was calcu-
lated from the difference between EDV and ESV divided
by the calf’s BW [15]. Cardiac index (CI) was calculated
from SI and HR [15].
Statistic analysis
Results of clinical biology and echocardiography were
analysed using a Statistical Analysis System (SAS) soft-
ware. A mixed model for repeated data was used. The
model included the effect of “day”, “group” and the
interaction “day” and “group”. Differences were consid-
ered significant if p ≤ 0.05.
Results
Clinical examination
Appetite was depressed in calves of group 2 from D3
until D6 of the experimentation. The careful examina-
tion of the tongue and the evaluation of suckle response
did not reveal significant findings. However, despite this
appetite decrease, calves ingested the whole planned
doxycycline dose. No other significant clinical modifica-
tions were observed during the experimentation.
Blood analysis
Serum enzymology results are shown in table 1. There
was no significant change in CK, Iso-CKs, AST and
LDH activities between D0 and D6 regardless of the
dosage of doxycycline received.
Electrocardiography
At D0, D4 and D6, no pathologic arrhythmias were
observed in any animal.
Echocardiography
Echocardiographic results are shown in Table 2. No sig-
nificant morphological or functional echocardiographic
changes were observed within or between groups.
Discussion
Several cases of doxycycline intoxication have been
reported in calves aged between 2 and 16 weeks, origi-
nating from different breeds (including BB calves), and
that received 3 to 10 times the recommended dose of
doxycycline [6-12]. In these cases, cardiac toxicity was
suggested by clinical signs (tachycardia, arrhythmias,
sudden death) and post-mortem examination (myocar-
dial necrosis). The purpose of the present study was to
experimentally reproduce the same troubles in calves
with age and breed comparable to those described in
previous papers. The major limitation of the present
study is the fact that no post-mortem examination was
performed. However, cardiac function of the studied
calves was investigated through clinical examination,
ECG, echocardiography and serum enzymology.
Previous studies on accidental doxycycline intoxication
in calves reported untoward clinical signs, leading to
sudden death in some cases, 1 to 5 days after oral doxy-
cycline overdosing [6-9,11,12]. In this experimental dox-
ycycline overdosing, only a decreased appetite was
clinically observed in doxycycline-overdosed calves. A
similar appetite decrease has also been previously
Table 1 Blood analysis results before (D0) and after (D6) 5 days administration of 5 mg/kg (Group 1) or 25 mg/kg
(Group 2) of oral doxycycline BID in 2 months-old healthy Belgian Blue calves.
Group 1 (n = 6) Group 2 (n = 6)
Reference
range
D0
Mean ± SD
D6
Mean ± SD
D0
Mean ± SD
D6
Mean ± SD
Group 1 vs Group 2
p
AST (IU/L) 70-130 77 ± 13 77 ± 16 62 ± 19 68 ± 23 NS
LDH (IU/L) 1691-2618 2464 ± 512 2578 ± 428 2031 ± 336 2169 ± 348 NS
CK (IU/L) 128-244 270 ± 257 306 ± 27 145 ± 37 191 ± 79 NS
Iso-CK MM (%) 55 ± 17 45 ± 21 39 ± 11 47 ± 16 NS
Iso-CK BB (%) 5 ± 2 4 ± 2 5 ± 2 3 ± 1 NS
Iso-CK MB (%) 3 ± 3 3 ± 2 3 ± 1 2 ± 1 NS
Iso-CK MT (%) 37 ± 14 49 ± 18 54 ± 12 49 ± 17 NS
AST: aspartate aminotransferase; LDH: lactate dehydrogenase; CK: creatine kinase; Iso-CK MM: muscle creatine kinase isoenzyme; Iso-CK BB: brain creatine kinase
isoenzyme; Iso-CK MB: heart creatine kinase isoenzyme; Iso-CK MT: mitochondrial creatine kinase isoenzyme; NS: not significant.
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ing [8,9]. Clinical evolution of the studied doxycycline-
overdosed calves was thus clinically completely distinct
from the clinical pattern reported in accidental cases.
No clinical signs suggestive of cardiomyopathy (such
as those reported by previous authors in field occurring
cases of doxycycline-overdosing) were detected after 5
days of doxycycline administration at 5 times the
recommended dose in the present study. Cardiac
arrhythmias are among the most common signs
observed with cardiomyopathy in cattle [17,18], cats
[19], dogs [20] and in human beings [21]. Cardiac
arrhythmias were also reported in accidentally field-
occurring doxycycline overdosed calves [9,11,12]. On
the contrary, in the present experimental doxycycline
overdosing, no cardiac arrhythmias were detected during
the daily clinical examination or on ECG examination
performed after 3 and 5 days of doxycycline administra-
tion. However, it would have been better to perform a
holter examination of the investigated calves to exclude
with greater certainty the occurrence of cardiac
arrhythmias.
Spectacular elevation of serum muscular enzymes
activity was reported in previous cases of doxycycline
intoxication in calves [9,12], suggesting skeletal muscles
damage possibly associated with myocardial damage
[22,23]. In the present study, clinical biology revealed
absolutely no modifications in serum CK, Iso-CKs,
LDH, Iso-LDHs and AST activities between D0 and D6
in calves that received either normal or high dose of
doxycycline. These results strongly suggest that no mus-
cle damage (including skeletal muscles and myocar-
dium) occurred between D0 and D6. Cardiac
isoenzymes of LDH and CK were amongst the first uti-
lized cardiac markers in human medicine [24]. However,
those cardiac biomarkers have been shown to have a
lack of specificity and a low sensitivity, so they are
almost no longer used in human patients. In veterinary
medicine, isoenzymes 1 and 2 of lactate dehydrogenase
and the MB fraction of creatine kinase are still used
because until recently, there were no alternative cardiac
biomarkers validated in animals. In the recent years, the
measurement of serum cardiac troponin I or T has
emerged as the biochemical “gold standard” for diagno-
sis of patients suffering from myocardial injury [25-27].
More recently, the measurement of this marker has
been validated in several animal species, and it has been
showed to be increased in animals, including cattle [28],
suffering from various cardiac diseases. The use of car-
diac troponin I was validated in cattle [29], but bovine
cardiac troponin T was not accurately quantified with a
common human clinical immunoassay [30]. It would
thus have been interesting to use cardiac troponin I in
the present study.
In this study, no cardiac morphological or functional
modifications were observed by echocardiography
between D0 and D6 in the 2 groups.
Left ventricular FS, EF and cardiac output (CO) are
common measurements of left ventricular systolic and
global function [15,31,32] and are expected to undergo
changes when myocardial performance is impaired [15].
In the present study, parameters of systolic function and
cardiac global performance (SI and CI) were preserved
even in overdosed calves. These results suggest that
overdosing doxycycline in healthy BB calves did not
affect their cardiac function.
Table 2 Echocardiographic parameters measured before (D0) and after (D6) administration of 5 mg/kg (Group 1) or 25
mg/kg (Group 2) of oral doxycycline BID during 5 consecutive days in 2 months-old healthy Belgian Blue calves.
Group 1 (n = 6) Group 2 (n = 6)
D0
Mean ± SD
D6
Mean ± SD
D0
Mean ± SD
D6
Mean ± SD
Group 1 vs Group 2
p
HR (beats/min) 108 ± 13 110 ± 10 83 ± 12 95 ± 27 NS
LVIDs (cm) 3.96 ± 0.42 3.65 ± 0.51 3.29 ± 0.61 3.40 ± 0.56 NS
LVIDd (cm) 5.67 ± 0.28 5.45 ± 0.46 4.91 ± 0.62 5.09 ± 0.64 NS
IVSs (cm) 1.86 ± 0.11 1.88 ± 0.10 1.84 ± 0.17 1.83 ± 0.17 NS
IVSd (cm) 1.11 ± 0.03 1.11 ± 0.10 1.12 ± 0.18 1.16 ± 0.14 NS
FS (%) 30.19 ± 6.74 33.22 ± 4.43 33.35 ± 6.25 33.40 ± 5.48 NS
% IVS 67.05 ± 6.74 69.91 ± 8.59 65.63 ± 20.28 58.33 ± 17.06 NS
EDV (cm
3) 158.40 ± 17.90 145.50 ± 19.99 115.51 ± 9.24 125.65 ± 22.68 NS
ESV (cm
3) 69.13 ± 17.20 57.72 ± 14.50 45.73 ± 12.27 49.08 ± 16.16 NS
SI (ml kg
-1beat
-1) 1.17 ± 0.27 1.01 ± 0.20 0.95 ± 0.14 1.04 ± 0.16 NS
CI (ml kg
-1 min
-1) 0.13 ± 0.04 0.11 ± 0.04 0.08 ± 0.03 0.10 ± 0.03 NS
EF 0.56 ± 0.09 0.61 ± 0.05 0.61 ± 0.06 0.61 ± 0.06 NS
HR: heart rate; LVIDs and LVIDd: left ventricular internal diameter in systole and diastole; IVSs and IVSd: interventricular septum thickness in systole and diastole;
FS: fractional shortening of the left ventricle; %IVS: fractional thickening of the interventricular septum; EDV: end diastolic volume; ESV: end systolic volume; SV:
stroke volume; SI: stroke index; CI: cardiac index; EF: ejection fraction.
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phical and echocardiographical results of this study sug-
gest that an experimentally-induced doxycycline
overdosing at 5 times the normal dose for 5 consecutive
days in healthy calves did not reproduce the cardiomyo-
pathy that has been reported in several calves receiving
high doses of doxycycline in the field. This means that
in the previous outbreaks of doxycycline-poisoning in
calves, overdosing doxycycline was not the only cause of
the reported myocardial necrosis. Some other exacerbat-
ing factors may play a role in the development of this
process.
Even if reported in a small number of calves, clinical
biology performed in doxycycline accidentally-overdosed
calves revealed low levels of blood vitamin E (one calf
out of two sampled) and selenium (two calves out of
two sampled) content [9]. On the other hand, post mor-
tem findings in doxycycline poisoned calves are very
similar to observations made on calves suffering from
vitamin E/selenium deficiency-associated myopathy and/
or cardiomyopathy. Vitamin E/selenium deficiency could
thus be a potential exacerbating factor and a potential
link between doxycycline-overdosing and vitamin E/sele-
nium metabolism may exist. Interaction between doxy-
cycline and other drugs may also be possible. Finally, a
delayed cardiac toxicity could also be suggested. In
some previous reports, signs of doxycycline toxicity
were observed after five days of doxycycline administra-
tion [6]. Even if reported only in one paper, this obser-
vation should not be ignored as well as the fact that
there can be individual variation among calves tolerance
to this drug.
Conclusions
Overdosing doxycycline at 5 times the recommended
dose for 5 consecutive days in healthy 2 months-old BB
calves did not result in clinical, electrocardiographic or
echocardiographic signs of cardiomyopathy. Therefore,
the myocardial lesions found in calves accidentally over-
dosed with doxycycline may be attributable to other yet
unknown factors.
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